Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
Ning Pang, Ji Li, Aning Sun, Zhenzhen Yang, Shixuan Cheng, Xian-Rong Qi Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China Background: Abnormal expression of stroma...
Guardado en:
Autores principales: | Pang N, Li J, Sun A, Yang Z, Cheng S, Qi XR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9daecfaf20a445759810fbe3dd20cf36 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles
por: Xu M, et al.
Publicado: (2021) -
Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen R, et al.
Publicado: (2021) -
Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
por: Xu M, et al.
Publicado: (2021) -
Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
por: Eiman Elwakeel, et al.
Publicado: (2021) -
CAF1-knockout mice are more susceptive to lipopolysaccharide-induced acute lung injury
por: Shi JX, et al.
Publicado: (2016)